The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1/2 study (MYCHELANGELO I) of first-in-class epigenomic controller OTX-2002 targeting MYC oncogene in patients with hepatocellular carcinoma (HCC) and other solid tumors.
 
Jonathan Mizrahi
Honoraria - AstraZeneca; Exelixis
Consulting or Advisory Role - Amgen; Daichii Sankyo; Exelixis; Seagen
Speakers' Bureau - AstraZeneca; Bristol Myers Squibb Foundation; Exelixis
 
William Senapedis
Employment - Omega Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics; Omega Therapeutics
Research Funding - Omega Therapeutics
 
Charles O'Donnell
Employment - Omega Therapeutics
Stock and Other Ownership Interests - Omega Therapeutics
Research Funding - Omega Therapeutics
 
J. Graeme Hodgson
Employment - Omega Therapeutics; Syros Pharmaceuticals
Stock and Other Ownership Interests - Omega Therapeutics; Syros Pharmaceuticals
Research Funding - Omega Therapeutics; Syros Pharmaceuticals
 
Joseph Newman
Employment - Omega Therapeutics
Stock and Other Ownership Interests - Omega Therapeutics
Research Funding - Omega Therapeutics
 
Stephen Siecinski
Employment - Omega Therapeutics
Stock and Other Ownership Interests - Omega Therapeutics
Research Funding - Omega Therapeutics
 
Chia-Chi Lin
Honoraria - Daiichi Sankyo; Lilly; Novartis; Novartis; Roche
Consulting or Advisory Role - Abbvie; Anbogen Therapeutics; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; IMPAC Medical Systems; Novartis; PharmaEngine
Travel, Accommodations, Expenses - BeiGene; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; IMPAC Medical Systems; Lilly